Gene · 6652
Papers2,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies. | Front Immunol | 2026 | 41737225 | PubTator, text mining | PubMed |
| Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes. | Cardiovasc Diabetol Endocrinol Rep | 2026 | 41703653 | PubTator, text mining | PubMed |
| Mechanistic evidence for dibutyl phthalate as an environmental trigger for inflammatory bowel disease. | iScience | 2026 | 41630903 | PubTator, text mining | PubMed |
| EAT-Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature. | Arthritis Rheumatol | 2026 | 40546003 | PubTator, text mining | PubMed |
| Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis. | Front Cardiovasc Med | 2025 | 41799894 | PubTator, text mining | PubMed |
| [Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. | Zhongguo Fei Ai Za Zhi | 2025 | 41777062 | PubTator, text mining | PubMed |
| Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM-1 Upregulation. | Exp Dermatol | 2025 | 41387231 | PubTator, text mining | PubMed |
| Targeting the polyol pathway in NSCLC: Trans-(±)-kusunokinin demonstrates anti-migratory and survival benefits in in vitro and in vivo models. | Biomed Pharmacother | 2025 | 41289874 | PubTator, text mining | PubMed |
| Gene-Pseudogene Inversions as a Hidden Source of Missing Heritability. | medRxiv | 2025 | 41282915 | PubTator, text mining | PubMed |
| Discovery of molecular signature of long-term psychiatric sequelae in COVID-19 through proteome profiling of dried blood spots. | Transl Psychiatry | 2025 | 41073392 | PubTator, text mining | PubMed |
| Identification of genes related to the effects of bicalutamide and zoladex on benign prostatic hyperplasia. | Sci Rep | 2025 | 40999058 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
| Fructose and glucose from sugary drinks enhance colorectal cancer metastasis via SORD. | Nat Metab | 2025 | 40973819 | PubTator, text mining | PubMed |
| Impacts of aging and fluid shear stress on vascular endothelial metabolism and atherosclerosis development. | J Biomed Sci | 2025 | 40890841 | PubTator, text mining | PubMed |
| Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy. | Eur J Neurol | 2025 | 40755160 | PubTator, text mining | PubMed |
| Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. | Signal Transduct Target Ther | 2025 | 40750772 | PubTator, text mining | PubMed |
| Computational screening identifies selective aldose reductase inhibitors with strong efficacy and limited off target interactions. | Sci Rep | 2025 | 40750639 | PubTator, text mining | PubMed |
| Neuromuscular pathology and mitochondrial dysfunction in sorbitol dehydrogenase gene-related distal hereditary motor neuropathies. | J Neuropathol Exp Neurol | 2025 | 40580554 | PubTator, text mining | PubMed |
| S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker. | Front Oncol | 2025 | 40567612 | PubTator, text mining | PubMed |
| Expanding the phenotype of SORD mutation. | Brain | 2025 | 40488316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6652/papers?page=2